FDA Clearance Tracker · P040012
ACCULINK CAROTID STENT SYSTEM AND RX ACCULINK CAROTID STENT SYSTEM
Last checked: Nov 19, 2026Latest source record: Aug 30, 2004 (this decision)Source: openFDAMethods & limitations
Decided
Aug 30, 2004
Approved
Time to decision
168 days
Received Mar 15, 2004. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P040012
- Device name
- ACCULINK CAROTID STENT SYSTEM AND RX ACCULINK CAROTID STENT SYSTEM
- Applicant
- Abbott Vascular
- Applicant location
- Santa Clara, CA
- Received
- Mar 15, 2004
- Decided
- Aug 30, 2004
- Decision
- Approved
- Expedited review
- Yes, flagged as expedited in FDA's record.
- Supplements
- 64 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- Stent, carotid (NIM)
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE ACCULINK CAROTID STENT SYSTEM AND RX ACCULINK CAROTID STENT SYSTEM. THE ACCULINK CAROTID STENT SYSTEM AND THE RX ACCULINK CAROTID STENT SYSTEM, USED IN CONJUNCTION WITH GUIDANT CAROTID EMBOLIC PROTECTION SYSTEMS, ARE INDICATED FOR THE TREATMENT OF PATIENTS AT HIGH RISK FOR ADVERSE EVENTS FROM CAROTID ENDARTERECTOMY WHO REQUIRE CAROTID REVASCULARIZATION AND MEET THE CRITERIA OUTLINED BELOW. 1) PATIENTS WITH NEUROLOGICAL SYMPTOMS AND >=50% STENOSIS OF THE COMMON OR INTERNAL CAROTID ARTERY BY ULTRASOUND OR ANGIOGRAM OR PATIENTS WITHOUT NEUROLOGICAL SYMPTOMS AND >=80% STENOSIS OF THE COMMON OR INTERNAL CAROTID ARTERY BY ULTRASOUND OR ANGIOGRAM, AND2) PATIENTS MUST HAVE A REFERENCE VESSEL DIAMETER WITHIN THE RANGE OF 4.0 MM AND 9.0 MM AT THE TARGET LESION.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code NIM (Stent, carotid).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Abbott Vascular
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- XACT Carotid Stent SystemPMA supplement
P040038-S043 · Decided Feb 7, 2024 · 225 days after receipt · Panel Track
Device type: Stent, carotid (NIM) · Cardiology
- Perclose ProStyle Suture-Mediated Closure and Repair System, Perclose ProGlide Suture-Mediated Closure SystemPMA supplement
P960043-S118 · Decided Jun 2, 2023 · 256 days after receipt · Panel Track
Device type: Device, hemostasis, vascular (MGB) · Cardiology
K220634 · Decided Jun 30, 2022 · 118 days after receipt
Device type: Catheters, Transluminal Coronary Angioplasty, Percutaneous (LOX) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.